Part-time Research Specialist in Radiotheranostic Cancer Drug Development
- Deadline
- 1 Dec 2026 · 9 days left
- Location
- Solna, Sweden
- Type
- Research Assistant
- Compensation
- Individual salary under RALS / RALS-T agreements (monthly)
- Duration
- 12 months · 1 year
- Working language
- English
- Posted
- 22 Nov 2026
- Verified
- 22 Nov 2026
About this opportunity
The Department of Oncology-Pathology at Karolinska Institutet in Solna, Sweden, is hiring a part-time research specialist to help develop radioactive drugs for cancer. The project works in radiotheranostics, which pairs PET imaging with targeted radionuclide therapy. The aim is to move a project from the preclinical stage towards clinical use. This is a one-year, fixed-term post at 20–25% of full time.
What is offered
- A fixed-term job at Karolinska Institutet for one year, at 20–25% of full time (one position).
- Work on new radiotheranostic drugs aimed at a specific cancer target. You will design targeting molecules, optimise radiolabelling and evaluate compounds in vitro and in vivo.
- A strong focus on translation, meaning moving the project from preclinical work into the clinic.
- Monthly pay set individually under the Swedish RALS and RALS-T agreements. No salary figure is given.
- Start date by agreement. The workplace is in Solna, Stockholm County.
Who can apply
- You must have a PhD or an equivalent foreign degree, plus documented research experience after your doctorate.
- Good knowledge of radiotheranostics, radiochemistry development and translational work is required.
- These count in your favour:
- a PhD in radiochemistry or a related field
- experience with GMP and GCP
- experience with in vitro cell assays and small-animal imaging
- experience leading projects and supervising master's students
- a record of winning research grants
- good communication skills
How to apply
- Apply through Karolinska Institutet's Varbi recruitment system, using the link in the job ad.
- You can write your application in English or Swedish. English is preferred.
- Include your doctoral diploma, CV, a description of your merits and a description of your planned research, following KI's merit portfolio format.
- The deadline is 1 December 2026. The reference number is STÖD 2-4628/2026.
- For questions about the role, contact Thuy Tran (thuy.tran@ki.se).
Requirements
-
Open to all nationalities
-
Early-career researcher
-
Minimum degree: PhD
Part-time Research Specialist in Radiotheranostic Cancer Drug Development
1 Dec 2026 · 9 days left